Guangzhou Kingmed Diagnostics Group Statistics

Total Valuation

Guangzhou Kingmed Diagnostics Group has a market cap or net worth of CNY 16.24 billion. The enterprise value is 15.19 billion.

Market Cap	16.24B
Enterprise Value	15.19B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jun 18, 2024

Share Statistics

Guangzhou Kingmed Diagnostics Group has 464.79 million shares outstanding. The number of shares has decreased by -0.18% in one year.

Current Share Class	n/a
Shares Outstanding	464.79M
Shares Change (YoY)	-0.18%
Shares Change (QoQ)	-2.90%
Owned by Insiders (%)	17.61%
Owned by Institutions (%)	29.31%
Float	304.16M

Valuation Ratios

The trailing PE ratio is 101.22 and the forward PE ratio is 25.79. Guangzhou Kingmed Diagnostics Group's PEG ratio is 1.72.

PE Ratio	101.22
Forward PE	25.79
PS Ratio	2.08
PB Ratio	2.07
P/TBV Ratio	n/a
P/FCF Ratio	30.51
P/OCF Ratio	n/a
PEG Ratio	1.72

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.59, with an EV/FCF ratio of 28.54.

EV / Earnings	94.26
EV / Sales	1.94
EV / EBITDA	21.59
EV / EBIT	130.21
EV / FCF	28.54

Financial Position

The company has a current ratio of 3.28, with a Debt / Equity ratio of 0.09.

Current Ratio	3.28
Quick Ratio	3.11
Debt / Equity	0.09
Debt / EBITDA	1.01
Debt / FCF	1.34
Interest Coverage	6.06

Financial Efficiency

Return on equity (ROE) is 1.85% and return on invested capital (ROIC) is 0.81%.

Return on Equity (ROE)	1.85%
Return on Assets (ROA)	0.63%
Return on Capital (ROIC)	0.81%
Revenue Per Employee	677,443
Profits Per Employee	13,914
Employee Count	11,586
Asset Turnover	0.68
Inventory Turnover	20.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.34% in the last 52 weeks. The beta is 0.66, so Guangzhou Kingmed Diagnostics Group's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	-49.34%
50-Day Moving Average	32.38
200-Day Moving Average	39.35
Relative Strength Index (RSI)	52.54
Average Volume (20 Days)	11,603,245

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Guangzhou Kingmed Diagnostics Group had revenue of CNY 7.85 billion and earned 161.20 million in profits. Earnings per share was 0.35.

Revenue	7.85B
Gross Profit	2.73B
Operating Income	116.69M
Pretax Income	209.07M
Net Income	161.20M
EBITDA	584.65M
EBIT	116.69M
Earnings Per Share (EPS)	0.35

Full Income Statement

Balance Sheet

The company has 1.94 billion in cash and 712.90 million in debt, giving a net cash position of 1.23 billion or 2.65 per share.

Cash & Cash Equivalents	1.94B
Total Debt	712.90M
Net Cash	1.23B
Net Cash Per Share	2.65
Equity (Book Value)	8.01B
Book Value Per Share	16.88
Working Capital	5.28B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.03 billion and capital expenditures -502.46 million, giving a free cash flow of 532.47 million.

Operating Cash Flow	1.03B
Capital Expenditures	-502.46M
Free Cash Flow	532.47M
FCF Per Share	1.15

Full Cash Flow Statement

Margins

Gross margin is 34.76%, with operating and profit margins of 1.49% and 2.05%.

Gross Margin	34.76%
Operating Margin	1.49%
Pretax Margin	2.66%
Profit Margin	2.05%
EBITDA Margin	7.45%
EBIT Margin	1.49%
FCF Margin	6.78%

Dividends & Yields

This stock pays an annual dividend of 0.88, which amounts to a dividend yield of 2.48%.

Dividend Per Share	0.88
Dividend Yield	2.48%
Dividend Growth (YoY)	-50.56%
Years of Dividend Growth	6
Payout Ratio	259.16%
Buyback Yield	0.18%
Shareholder Yield	2.65%
Earnings Yield	0.99%
FCF Yield	3.28%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Guangzhou Kingmed Diagnostics Group has an Altman Z-Score of 6.49.

Altman Z-Score	6.49
Piotroski F-Score	n/a